LOS ANGELES CAPITAL MANAGEMENT LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$515,000
-33.8%
63,299
-21.9%
0.00%
-50.0%
Q2 2020$778,000
+95.0%
81,016
+37.9%
0.00%
+33.3%
Q1 2020$399,000
-10.7%
58,746
+95.7%
0.00%
+50.0%
Q4 2019$447,000
+84.7%
30,018
+27.0%
0.00%
+100.0%
Q3 2019$242,000
+114.2%
23,633
+121.1%
0.00%0.0%
Q2 2019$113,00010,6900.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders